Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

(±)-Tazifylline

🥰Excellent
Catalog No. T10000Cas No. 79712-55-3

(±)-Tazifylline is a selective and long-acting antagonist of histamine H1 receptor. Tazifylline shows much lower affinity for H2 receptors, α- and β-adrenoceptors, 5-hydroxytryptamine and muscarinic receptor subtypes.

(±)-Tazifylline

(±)-Tazifylline

🥰Excellent
Purity: 98.97%
Catalog No. T10000Cas No. 79712-55-3
(±)-Tazifylline is a selective and long-acting antagonist of histamine H1 receptor. Tazifylline shows much lower affinity for H2 receptors, α- and β-adrenoceptors, 5-hydroxytryptamine and muscarinic receptor subtypes.
Pack SizePriceAvailabilityQuantity
1 mg$151In Stock
5 mg$298In Stock
10 mg$433In Stock
25 mg$678In Stock
50 mg$912In Stock
100 mg$1,180In Stock
1 mL x 10 mM (in DMSO)$389In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "(±)-Tazifylline"

Select Batch
Purity:98.97%
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
(±)-Tazifylline is a selective and long-acting antagonist of histamine H1 receptor. Tazifylline shows much lower affinity for H2 receptors, α- and β-adrenoceptors, 5-hydroxytryptamine and muscarinic receptor subtypes.
In vitro
Tazifylline potently inhibits histamine H1-receptor-induced contractions in isolated guinea pig ilea and demonstrates high affinity in radioligand binding studies[1].
In vivo
In anesthetized guinea pigs, Tazifylline causes an inhibition in histamine-induced bronchoconstriction and protects conscious animals from the lethal effect of large doses of the amine. In conscious rats, Tazifylline reduces the inflammatory effects of intradermal histamine. In conscious dogs, Tazifylline(orally) causes inhibition in histamine-induced skin inflammation for long periods of time, and in anesthetized animals attenuated that portion of the histamine-evoked hypotension attributable to stimulation of H1 receptors. Large oral doses of Tazifylline do not reduce spontaneous locomotor activity in mice, nor do they produce overt symptoms of behavioral depression in conscious rats[1].
Chemical Properties
Molecular Weight472.6
FormulaC23H32N6O3S
Cas No.79712-55-3
SmilesC(C(CN1CCN(CCCSC2=CC=CC=C2)CC1)O)N3C4=C(N=C3)N(C)C(=O)N(C)C4=O
Relative Density.1.34g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 45 mg/mL (95.22 mM)
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM2.1160 mL10.5798 mL21.1595 mL105.7977 mL
5 mM0.4232 mL2.1160 mL4.2319 mL21.1595 mL
10 mM0.2116 mL1.0580 mL2.1160 mL10.5798 mL
20 mM0.1058 mL0.5290 mL1.0580 mL5.2899 mL
50 mM0.0423 mL0.2116 mL0.4232 mL2.1160 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy (±)-Tazifylline | purchase (±)-Tazifylline | (±)-Tazifylline cost | order (±)-Tazifylline | (±)-Tazifylline chemical structure | (±)-Tazifylline in vivo | (±)-Tazifylline in vitro | (±)-Tazifylline formula | (±)-Tazifylline molecular weight